127 related articles for article (PubMed ID: 11426017)
1. Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
Furst DE; Clements PJ; Wong WK; Mayes MD; Wigley F; White B; Weisman M; Barr W; Moreland L; Martin R; Medsger TA; Steen V; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Peter JB; Seibold JR
Rheumatology (Oxford); 2001 Jun; 40(6):615-22. PubMed ID: 11426017
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.
White B; Bauer EA; Goldsmith LA; Hochberg MC; Katz LM; Korn JH; Lachenbruch PA; LeRoy EC; Mitrane MP; Paulus HE
Arthritis Rheum; 1995 Mar; 38(3):351-60. PubMed ID: 7880189
[TBL] [Abstract][Full Text] [Related]
3. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
4. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Clements PJ; Seibold JR; Furst DE; Mayes M; White B; Wigley F; Weisman MD; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Wong WK
Semin Arthritis Rheum; 2004 Feb; 33(4):249-63. PubMed ID: 14978663
[TBL] [Abstract][Full Text] [Related]
5. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
[TBL] [Abstract][Full Text] [Related]
6. Performance of the new American College of Rheumatology classification criteria in Turkish systemic sclerosis patients: a multicenter study.
Pamuk ON; Balcı MA; Onat AM; Zengin O; Cakır N; Kısacık B
Clin Rheumatol; 2016 Feb; 35(2):357-61. PubMed ID: 26643772
[TBL] [Abstract][Full Text] [Related]
7. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
Clements PJ; Hurwitz EL; Wong WK; Seibold JR; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen VD; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Furst DE
Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
[TBL] [Abstract][Full Text] [Related]
8. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
9. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.
Hoffmann-Vold AM; Gunnarsson R; Garen T; Midtvedt Ø; Molberg Ø
J Rheumatol; 2015 Jan; 42(1):60-3. PubMed ID: 25274890
[TBL] [Abstract][Full Text] [Related]
10. Applying the ACR/EULAR Systemic Sclerosis Classification Criteria to the Spanish Scleroderma Registry Cohort.
Sáez-Comet L; Simeón-Aznar CP; Pérez-Conesa M; Vallejo-Rodríguez C; Tolosa-Vilella C; Iniesta-Arandia N; Colunga-Argüelles D; Egurbide-Arberas MV; Ortego-Centeno N; Vargas-Hitos JA; Freire-Dapena M; Rubio-Rivas M; Ríos-Blanco JJ; Trapiella-Martínez L; Fonollosa-Pla V;
J Rheumatol; 2015 Dec; 42(12):2327-31. PubMed ID: 26472418
[TBL] [Abstract][Full Text] [Related]
11. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
[TBL] [Abstract][Full Text] [Related]
12. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
[TBL] [Abstract][Full Text] [Related]
13. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
[TBL] [Abstract][Full Text] [Related]
14. D-penicillamine in systemic sclerosis? Yes!
Medsger TA; Lucas M; Wildy KS; Baker C
Scand J Rheumatol; 2001; 30(4):192-4. PubMed ID: 11578011
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.
Ingegnoli F; Carmona L; Castrejon I
Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740
[TBL] [Abstract][Full Text] [Related]
16. D-penicillamine is not an effective treatment in systemic sclerosis.
Furst DE; Clements PJ
Scand J Rheumatol; 2001; 30(4):189-91. PubMed ID: 11578010
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
18. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
Rook AH; Freundlich B; Jegasothy BV; Perez MI; Barr WG; Jimenez SA; Rietschel RL; Wintroub B; Kahaleh MB; Varga J
Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
[TBL] [Abstract][Full Text] [Related]
19. RISE-SSc: Riociguat in diffuse cutaneous systemic sclerosis.
Distler O; Pope J; Denton C; Allanore Y; Matucci-Cerinic M; de Oliveira Pena J; Khanna D
Respir Med; 2017 Jan; 122 Suppl 1():S14-S17. PubMed ID: 27746061
[TBL] [Abstract][Full Text] [Related]
20. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.
Zulian F; Woo P; Athreya BH; Laxer RM; Medsger TA; Lehman TJ; Cerinic MM; Martini G; Ravelli A; Russo R; Cuttica R; de Oliveira SK; Denton CP; Cozzi F; Foeldvari I; Ruperto N
Arthritis Rheum; 2007 Mar; 57(2):203-12. PubMed ID: 17330294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
